- Most head-and-neck cancers respond to Boron Neutron Capture Therapy (BNCT) (17.8.2007)
- BIOCENTRUM HELSINKI; CALL FOR RESEARCH GROUPS (16.4.2007)
- Call for Research Program Applications for the Years 2007-2011 (24.1.2006)
- Finnish Mobidiag announces its first product in the Prove It product family (24.9.2005)
- Biomedicum Helsinki Lecture (22.9.2005)
- Professor Tomi Mäkelä as Director of Biomedicum Helsinki (29.10.2004)
- BIOMEDICUM HELSINKI LECTURE (26.11.2003)
- A gene responsible for lymphatic vessel formation (25.11.2003)
- Finnish Mobidiag to international biochip markets (29.10.2003)